Cholinergic Nicotinic Agonist [EPC]

50957 reported adverse events

Drugs of this class: NICOTINE POLACRILEX NICOTINE NICOTINE TRANSDERMAL SYSTEM AROAMAS NICOTINE TRANSDERMAL PATCHES - STOP SMOKING AID ARSENICUM ALB., BENZOICUM ACIDUM, BERBER. VULG., BRYONIA, CALADIUM SEGUINUM, CANTHARIS, CEANOTHUS, CHELIDONIUM MAJUS, CHIONANTHUS VIRGINICA, CINCHONA, DAPHNE INDICA, IGNATIA, IRIS VERSICOLOR, LYCOPODIUM, NICOTINUM, NUX VOM., RHUS TOXICODENDRON, SCUTELLARIA LATERIFLORA, TABACUM, ECHINACEA, TARAXACUM, VALERIANA DAVV NICOTINE TRANSDERMAL PATCHES - STOP SMOKING AID LYMPH SYSTEM BOOSTER NICOITNE POLACRILEX NICOTINE POLACRILEX LOZENGE 2 MG NICOTINE POLACRILEX LOZENGE 4 MG NICOTINE POLARILEX NICOTINE TRANSDERMAL SYSTEM PATCH

These side effects are most commonly reported by patients taking drugs of the Cholinergic Nicotinic Agonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 5900
1 NICOTINE DEPENDENCE 5750
2 NAUSEA 3905
3 INTENTIONAL DRUG MISUSE 3783
4 APPLICATION SITE ERYTHEMA 3356
5 APPLICATION SITE PRURITUS 3293
6 PRODUCT QUALITY ISSUE 2392
7 DIZZINESS 2344
8 MALAISE 1974
9 PRODUCT ADHESION ISSUE 1802
See all common reactions for Cholinergic Nicotinic Agonist [EPC]

Drugs of the Cholinergic Nicotinic Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NICOTINE DEPENDENCE 5750 0.7975
1 TOBACCO POISONING 55 0.5978
2 RHESUS INCOMPATIBILITY 63 0.5943
3 APPLICATION SITE BRUISING 35 0.5738
4 TRUNCUS ARTERIOSUS PERSISTENT 59 0.3576
5 APPLICATION SITE HYPERAESTHESIA 28 0.3182
6 MYOCARDIAL STUNNING 25 0.2976
7 APPLICATION SITE DERMATITIS 249 0.2929
8 APPLICATION SITE URTICARIA 477 0.2363
9 APPLICATION SITE EXCORIATION 15 0.2308
See all enriched reactions for Cholinergic Nicotinic Agonist [EPC]